NO_LONGER_AVAILABLENCT02925520
Expanded Access Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Liver Injury in Children
Studying Parenteral nutrition-associated cholestasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Cook Children's Health Care System
- Principal Investigator
- Bankole O Osuntokun, MD, MSCook Children's Medical Center
- Intervention
- Omegaven(drug)
- Eligibility
- 5 years · All sexes
Study locations (1)
- Cook Children's Medical Center, Fort Worth, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02925520 on ClinicalTrials.govOther trials for Parenteral nutrition-associated cholestasis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06274788Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven TreatmentFresenius Kabi
- RECRUITINGPHASE4NCT06049680Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult PatientsFresenius Kabi
See all trials for Parenteral nutrition-associated cholestasis →